- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Apogee Technology, Inc. (AMEX:ATA), an emerging micro-systems and nanotechnology company that designs, develops and commercializes medical devices and sensor products, will hold a conference call to discuss its First Quarter 2007 results and recent developments on Wednesday, May 16, 2007, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time).
This call is being webcast by CCBN and can be accessed at Apogee's web site at http://www.apogeemems.com .
The call can also be accessed via teleconference using the following dial-in and passcode numbers:
Dial In # 866-831-6247
International Dial In # 617-213-8856
Participant Passcode 17384781
The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at http://www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents ( http://www.streetevents.com ).
About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its MEMS and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm(TM) solution for enhanced intradermal drug delivery and has introduced a family of pressure sensors under the Sensilica(R) brand. Apogee's goal is to provide value-added and cost-saving solutions for our customers and, in so doing, become a global leader in the sensor and medical device fields. For more information please visit our web site at: http://www.apogeemems.com .
PyraDerm(TM) and Sensilica(R) are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "hope," "estimate," "project," "will," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the Company to be materially different from those that may be expressed or implied. Please refer to the company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.
For more information, please click here
Apogee Investor Contact
Premier Funding & Financial Marketing
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Chains of nanogold – forged with atomic precision September 23rd, 2016
Speedy bacteria detector could help prevent foodborne illnesses September 21st, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
Fighting cancer with sticky nanoparticles September 27th, 2016
UNAM develops successful nano edible coating which increases life food September 27th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016
Nanobiotix revenue for Q2 2016 July 14th, 2016
Iran to hold intl. school on application of nanomaterials in medicine September 20th, 2016